Compound Detail
CHEMBL117287
PRUCALOPRIDE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL117287 |
| Name | PRUCALOPRIDE |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | ZPMNHBXQOOVQJL-UHFFFAOYSA-N |
| Therapeutic | ✓ Yes |
3
Targets
10
Activities
2
Assay Types
4
PK Parameters
20
Publications
5
Known Names
8
Indications
1
Mechanisms
Molecular Properties
367.9
MW (Da)
2.09
ALogP
5
HBA
2
HBD
76.8
PSA (Ų)
0.59
QED
0
Ro5 Violations
6
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 2009 |
| Availability | Prescription |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Serotonin 4 (5-HT4) receptor agonist | AGONIST | 5-hydroxytryptamine receptor 4 | ✓ | ✓ |
Indications
Constipation Intestinal Pseudo-Obstruction Deglutition Disorders Ileus Irritable Bowel Syndrome Dyspepsia Liver Diseases Depressive Disorder
ATC Classification
A06AX05
prucalopride
Level 1: ALIMENTARY TRACT AND METABOLISM
Level 2: DRUGS FOR CONSTIPATION
Activity Summary
EC50 5 meas. best 8.28
Ki 5 meas. best 8.6
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| 5-hydroxytryptamine receptor 4 CHEMBL1875 | Ki | 8.6 | 7.76 | 2.5 | 4 |
| 5-hydroxytryptamine receptor 4 CHEMBL1875 | EC50 | 8.28 | 8.0467 | 5.2 | 3 |
| 5-hydroxytryptamine receptor 4 CHEMBL4317 | EC50 | 7.58 | 7.58 | 26.0 | 2 |
| 5-hydroxytryptamine receptor 3A CHEMBL1899 | Ki | 5.4 | 5.4 | 3981.1 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 828.0 | ng.hr.mL-1 | Rattus norvegicus |
| CL | 113.0 | mL.min-1.kg-1 | Rattus norvegicus |
| Cmax | 774.71 | nM | Rattus norvegicus |
| F | 84.0 | % | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.6019/CHEMBL5724801 | U2OS | 304 |
| - | 10.6019/CHEMBL5058577 | HEK-293T | 304 |
| - | 10.6019/CHEMBL5058577 | U2OS | 304 |
| - | 10.6019/CHEMBL5058577 | Fibroblast | 304 |
| - | 10.6019/CHEMBL5724801 | Fibroblast | 304 |
| - | 10.6019/CHEMBL5724801 | HEK-293T | 304 |
| 15646539 | 10.1016/s0399-8320(04)95062-2 | Unchecked | 11 |
| 15646539 | 10.1016/s0399-8320(04)95062-2 | NON-PROTEIN TARGET | 8 |
| - | 10.6019/CHEMBL5058564 | U2OS | 6 |
| - | 10.6019/CHEMBL5058564 | Fibroblast | 6 |
| - | 10.6019/CHEMBL5209801 | Beta-2 adrenergic receptor | 5 |
| - | 10.6019/CHEMBL5209801 | Alpha-2A adrenergic receptor | 5 |
| - | 10.6019/CHEMBL5209801 | Adhesion G-protein coupled receptor F1 | 5 |
| - | 10.6019/CHEMBL5209801 | Glucagon-like peptide 1 receptor | 5 |
| - | 10.6019/CHEMBL5209801 | Apelin receptor | 5 |
| - | 10.6019/CHEMBL5209801 | Type-1 angiotensin II receptor | 5 |
| - | 10.6019/CHEMBL5209801 | C5a anaphylatoxin chemotactic receptor 1 | 5 |
| - | 10.6019/CHEMBL5209801 | Glucose-dependent insulinotropic receptor | 5 |
| - | 10.6019/CHEMBL5209801 | Free fatty acid receptor 4 | 5 |
| - | 10.6019/CHEMBL5209801 | N-formyl peptide receptor 2 | 5 |
Data from ChEMBL 36 via Core Engine